We are monitoring the impact of COVID-19 on MEA Non-Invasive Prenatal Testing Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2705
Share on
Share on

Middle East & Africa Non-Invasive Prenatal Testing Market Research Report - Segmented By Instruments, By Method, By Application, By End User, & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Analysis on Market Size, Share, Growth, Trends & Forecast | 2019 – 2024

Pulished: February, 2020
ID: 2705
Pages: 130

MEA Non-Invasive Prenatal Testing Market Size & Growth (2019-2024)

As per this report, the size of the Middle East & Africa Non-Invasive Prenatal Testing Market was valued at USD 0.12 Billion in 2019 and is projected to be growing at a CAGR of 4.93%, to touch USD 0.16 billion by 2024 during the forecast period 2019 - 2024.

Non-Invasive Prenatal Testing is used to identify the most common chromosome anomalies like Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and the Patau Syndrome (Trisomy 13). The gender of a fetus can also be determined using NIPT.

Non-Invasive Prenatal Testing (NIPT) is a new category of genetic test that screens for inherited ailments and birth defects. It usually involves a simple blood screening that examines the DNA, known as cell-free DNA(cf-DNA) to precisely assess a baby’s risk for a variety of genetic disorders, such as Down syndrome.

The growth of the market is mainly driven by factors such as the introduction of newer and more advanced NIPT products and the feasibility and growing preference for non-invasive techniques over invasive ones. The market faces quite a few restraints such as low awareness among the populace about genetic disorders, very low capital investment by companies to tap untapped markets and boost the market growth. The above restraints coupled with the low clinical validity of NIPT are dimming the market growth in this region.

This research report has been segmented and sub-segmented into the following categories

  • By Instruments: Ultrasound, NGS, PCR and Microarray
  • By Method: FCMB and Cf-DNA
  • By Application: Trisomy, Microdeletion, Genetics and Rh Factor
  • By End User: Hospital and Diagnostic Labs
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan and rest of MEA

Key market participants in the market profiled in the report are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Non-Invasive Prenatal Testing Market By Instruments, From 2019-2024 ( USD Billion )
  2. Middle East & Africa Ultrasound Market By Region, From 2019-2024 ( USD Billion )
  3. Middle East & Africa NGS Market By Region, From 2019-2024 ( USD Billion )
  4. Middle East & Africa PCR Market By Region, From 2019-2024 ( USD Billion )
  5. Middle East & Africa Microarray Market By Region, From 2019-2024 ( USD Billion )
  6. Middle East & Africa Non-Invasive Prenatal Testing Market By Method, From 2019-2024 ( USD Billion )
  7. Middle East & Africa FCMB Market By Region, From 2019-2024 ( USD Billion )
  8. Middle East & Africa cf-DNA Market By Region, From 2019-2024 ( USD Billion )
  9. Middle East & Africa Non-Invasive Prenatal Testing Market By Application, From 2019-2024 ( USD Billion )
  10. Middle East & Africa Trisomy Market By Region, From 2019-2024 ( USD Billion )
  11. Middle East & Africa Microdeletion Market By Region, From 2019-2024 ( USD Billion )
  12. Middle East & Africa Genetics Market By Region, From 2019-2024 ( USD Billion )
  13. Middle East & Africa Rh Factor Market By Region, From 2019-2024 ( USD Billion )
  14. Middle East & Africa Non-Invasive Prenatal Testing Market By End User, From 2019-2024 ( USD Billion )
  15. Middle East & Africa Hospital Market By Region, From 2019-2024 ( USD Billion )
  16. Middle East & Africa Diagnostic Labs Market By Region, From 2019-2024 ( USD Billion )
  17. Middle East Non-Invasive Prenatal Testing Market By Instruments, From 2019-2024 ( USD Billion )
  18. Middle East Non-Invasive Prenatal Testing Market By Method, From 2019-2024 ( USD Billion )
  19. Middle East Non-Invasive Prenatal Testing Market By Application, From 2019-2024 ( USD Billion )
  20. Middle East Non-Invasive Prenatal Testing Market By End User, From 2019-2024 ( USD Billion )
  21. Africa Non-Invasive Prenatal Testing Market By Instruments, From 2019-2024 ( USD Billion )
  22. Africa Non-Invasive Prenatal Testing Market By Method, From 2019-2024 ( USD Billion )
  23. Africa Non-Invasive Prenatal Testing Market By Application, From 2019-2024 ( USD Billion )
  24. Africa Non-Invasive Prenatal Testing Market By End User, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample